Sun extends tender offer for Taro; mediation fails
This article was originally published in Scrip
Executive Summary
Alkaloida Chemical Company Exclusive Group, a subsidiary of Sun Pharmaceutical Industries, has extended the closing date of its tender offer for the purchase of all outstanding ordinary shares of Taro Pharmaceutical Industries to April 17th from April 3rd.